Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI vs FP/SAL in COPD
NCT01323634Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of fluticasone, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Mar 2011; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01323634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323634.